Atherothrombosis at a distance: Contributing role of existing large-burden vascular disease, circulating biosignals and modulating extravascular tissues

Thrombosis Research

Volumn 119, Issue 6, 2007, Pages 761-768

  Becker, Richard C ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HEAT SHOCK PROTEIN; THROMBIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CORONARY BLOOD VESSEL; CYTOKINE PRODUCTION; DISEASE MARKER; HUMAN; INFLAMMATION; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOSIS; VASCULAR DISEASE; VASCULAR TISSUE;

AORTIC DISEASES; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; HUMANS; INFLAMMATION; OBESITY; PARACRINE COMMUNICATION; SIGNAL TRANSDUCTION; THROMBOSIS; VASCULAR DISEASES;

EID: 33947304183     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.05.014     Document Type: Article

References (71)

1. Oei H.H., Vliegenthart R., Hak A.E., Iglesias del Sol A., Hofman A., Oudkerk M., et al. The association between coronary calcification assessed by electron beam computed tomography and measures of extracoronary atherosclerosis: the Rotterdam Coronary Calcification Study. J Am Coll Cardiol 39 (2002) 1745-1751
2. Witteman J.C., Kok F.J., van Saase J.L., and Valkenburg H.A. Aortic calcification as a predictor of cardiovascular mortality. Lancet 2 (1986) 1120-1122
3. Wilson P.W., Kauppila L.I., O'Donnell C.J., Kiel D.P., Hannan M., Polak J.M., et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 103 (2001) 1529-1534
4. van der Meer I.M., Bots M.L., Hofman A., del Sol A.I., van der Kuip D.A.M., and Witteman J.C.M. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 109 (2004) 1089-1094
5. Davies M.J., Richardson P.D., Woolf N., Katz D.R., and Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage and smooth muscle cell content. Br Heart J 69 (1993) 377-381
6. Moreno P.R., Falk E., Palacios I.F., Newell J.B., Fuster V., and Fallon J.T. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 90 (1994) 775-778
7. Galis Z.S., Sukhova G.K., Kranzhofer R., Clark S., and Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A 92 (1995) 402-406
8. Amento E.P., Ehsani N., Palmer H., and Libby P. Cytokines positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 11 (1991) 1223-1230
9. Hanson G.K., Holm J., and Jonasson L. Detection of activated T lymphocytes in human atherosclerotic plaque. Am J Pathol 135 (1989) 169-175
10. Zhu J., Katz R.J., Quyyumi A.A., Canos D.A., Rott D., Csako G., et al. Association of serum antibodies to heat-shock protein 65 with coronary calcification levels: suggestion of pathogen-triggered autoimmunity in early atherosclerosis. Circulation 109 (2004) 36-41
11. null T cells in patients with acute coronary syndromes. Circulation 109 (2004) 1230-1235
12. Coughlin S.R. Thrombin signaling and protease activated receptors. Nature 407 (2000) 258-264
13. Coughlin S.R., and Camerer E. PARticipation in inflammation. J Clin Invest 111 (2003) 25-27
14. Vergnolle N., Wallace J.L., Bunnett N.W., and Hollenberg M.D. Protease activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 22 (2001) 146-152
15. Cheung W.M., D'Andrea M.R., Andrade-Gordon P., and Damiano B.P. Altered vascular injury responses in mice deficient in protease activated receptor-1. Arterioscler Thromb Vasc Biol 19 (1999) 3014-3024
16. Klarenbach S.W., Chipiuk A., Nelson R.C., Hollenberg M.D., and Murray A.G. Differential actions of PAR2 and PAR1 in stimulating human endothelial cell exocytosis and permeability: the role of Rho-GTPases. Circ Res 92 (2003) 272-278
17. Packham M.A., Guccione M.A., Kinlough-Rathbone R.L., and Mustard J.F. Platelet sialic acid and platelet survival after aggregation by ADP. Blood 56 (1980) 876-880
18. Kinlough-Rathbone R.L., Packham M.A., Guccione M.A., Richardson M., Harfenist E.J., and Mustard J.F. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation. Thromb Haemost 65 (1991) 403-410
19. Lindemann S., McIntyre T.M., Prescott S.M., Zimmerman G.A., and Weyrich A.S. Expanding the functional repertoire of platelets in thrombosis and inflammation: signal-dependent protein synthesis. In: Fitzgerald D.J., and Quinn M.J. (Eds). Platelet Function: Assessment, Diagnosis, and Treatment (2003), The Humana Press Inc., Totowa
20. 2+ concentration. Biochemistry 34 (1995) 9277-9281
21. Lindemann S., Tolley N.D., Dixon D.A., McIntyre T.M., Prescott S.M., Zimmerman G.A., et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 154 (2001) 485-490
22. Weyrich A.S., Elstad M.R., McEver R.P., McIntyre T.M., Moore K.L., Morrissey J.H., et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 97 (1996) 1525-1534
23. Galt S.W., Lindemann S., Medd D., Allen L.L., Kraiss L.W., Harris E.S., et al. Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets. Circ Res 89 (2001) 509-516
24. Lehr H.A., Weyrich A.S., Saetzler R.K., Jurek A., Arfors K.E., Zimmerman G.A., et al. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J Clin Invest 99 (1997) 2358-2364
25. Issekutz A.C., Ripley M., and Jackson J.R. Role of neutrophils in the deposition of platelets during acute inflammation. Lab Invest 49 (1983) 716-724
26. Neumann F.J., Ott I., Gawaz M., Richardt G., Holzapfel H., Jochum M., et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92 (1995) 748-755
27. Furman M.I., Becker R.C., Yarzebski J., Savegeau J., Gore J.M., and Goldberg R.J. Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol 78 (1996) 945-948
28. NOS expression and bioactivity in human aortic endothelial cells. Circulation 106 (2002) 1439-1441
29. Pasceri V., Willerson J.T., and Yeh E.T.H. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 (2000) 2165-2168
30. Baldus S., Heeschen C., Meinertz T., Zeiher A.M., Eiserich J.P., Münqel T., et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108 (2003) 1440-1445
31. Herbert J., Bono F., Herault J., Avril C., Dol F., Mares A., and Schaeffer P. Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo. J Clin Invest 101 (1998) 993-1000
32. Schaeffer P., Mares A.M., Dol F., Bono F., and Herbert J.M. Coagulation factor Xa induces endothelium-dependent relaxations in rat aorta. Circ Res 81 (1997) 824-828
33. Goel M.S., and Diamond S.L. Neutrophil enhancement of fibrin deposition under flow through platelet-dependent and independent mechanisms. Arterioscler Thromb Vasc Biol 21 (2001) 2093-2098
34. Mutch N.J., Robbie L.A., and Booth N.A. Human thrombin contain an abundance of active thrombin. Thromb Haemost 86 (2001) 1028-1034
35. 3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 106 (2002) 2111-2117
36. Vasa M., Herbert J., Bono F., Herault J., Avril C., Dol F., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) e1-e7
37. Verma S., Kuliszewski M.A., Mickle D.A.G., Weisel R.D., Fedak P.W.M., Li S.H., et al. C-reactive protein attenuates endothelial progenitor cell survival and differentiation. (Abstract). Can J Cardiol 18 suppl B (2002) 325
38. Fontaine V., Jacob M.P., Houard X., Rossignol P., Plissonnier D., Angles-Cano E., et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 161 (2002) 1701-1710
39. Sangiorgi G., D'Averio R., Mauriello A., Bondio M., Pontill M., Castelvecchio S., et al. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation 104 (2001) 1288-1295
40. Touat A., Ollivier V., Dai J., Huisse M.G., Bezeaud A., Sebbag U., et al. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol 168 (2006) 1022-1030
41. Seo D., Wang T., Dressman H., Herderick E.E., Iversen E.S., Vata K., et al. Gene expression phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol 24 (2004) 192
42. Vainas T., Lubbers T., Stassen F.R.M., Herngreen S.B., van Dieijen-Visser M.P., Bruggeman C., et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 107 (2003) 1103
43. Venugopal S.K., Devaraj S., and Jialal I. Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells. Am J Pathol 166 (2005) 1265-1271
44. Karra R., Vemullapalli S., Dong C., Herderick E.E., Xong X., Slosek K., et al. Molecular evidence for arterial repair in atherosclerosis. Proc Natl Acad Sci U S A 102L (2005) 16789-16794
45. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
46. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Centers for Disease Control and Prevention, American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for health professionals from the Centers for Disease Control and the American Heart Association. Circulation 107 (2003) 499-511
47. Blankenberg S., Luc G., Ducimetiére P., Dominique A., Ferriéres J., Amouyel P., et al. Interleukin-18 and the risk of coronary heart disease in European men. Circulation 108 (2003) 2453-2459
48. Cesari M., Penninx B.W.J.H., Newman A.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrrell K., et al. Inflammatory markers and onset of cardiovascular events. Results from the Health ABC Study. Circulation 108 (2003) 2317-2322
49. Mattila K.J., Valle M.S., Nieminen M.S., Valtonen V.V., and Hietaniemi K.L. Dental infections and coronary atherosclerosis. Atherosclerosis 103 (1993) 205-211
50. Genco R.J., Wu T.J., Grossi S., Falkner K., Zambon J.J., and Trevisan M. Periodontal microflora related to the risk for myocardial infarction: a case control study. J Dent Res 78 (1999) 457 [Abstract]
51. Emingil G., Buduneli E., Aliyev A., Akilli A., and Atilla G. Association between periodontal disease and acute myocardial infarction. J Periodontol 71 (2000) 1882-1886
52. Grau A.J., Buggle F., Ziegler C., Schwarz W., Meuser J., Tasman A.J., et al. Association between acute cerebrovascular ischemia and chronic and recurrent infection. Stroke 28 (1997) 1724-1729
53. Loesche W.J., Schork A., Terpenning M.S., Chen Y.M., Kerr C., and Dominguez B.L. The relationship between dental disease and cerebral vascular accident in elderly United States veterans. Ann Periodontol 3 (1998) 161-174
54. Lowe G., Woodward M., Rumley A., Morrison C., Tunstall-Pedoe H., and Stephen K. Total tooth loss and prevalent cardiovascular disease in men and women: possible roles of citrus fruit consumption, vitamin C, and inflammatory and thrombotic variables. J Clin Epidemiol 56 (2003) 264-700
55. Janket S., Qvarnström, Meurman J.H., Baird A.E., Nuutinen P., and Jones J.A. Asymptotic dental score and prevalent coronary heart disease. Circulation 109 (2004) 1095-1100
56. Joshipura K.J., Rimm E.B., Douglass C.W., Trichopoulos D., Ascherio A., and Willett W.C. Poor oral health and coronary heart disease. J Dent Res 75 (1996) 1631-1636
57. Joshipura K.J., Hung H.C., Rimm E.B., Willett W.C., and Ascherio A. Periodontal disease, tooth loss, and incidence of ischemic stroke. Stroke 34 (2003) 47-52
58. Sattar N., McCarey D.W., Capell H., and McInnes I.B. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108 (2003) 2957-2963
59. Van Doornum S., McColl G., and Wicks I.P. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?. Arthritis Rheum 46 (2002) 862-873
60. Pasceri V., and Yeh E.T. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 100 (1999) 2124-2126
61. Choi H.K., Herman M.A., Seeger J.D., Robins J.M., and Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 22 (2002) 1745-1750
62. McEntegart A., Capell H.A., Creran D., Rumley A., Woodward M., and Lowe G.D. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology 40 (2001) 640-644
63. Grignani G., and Maiolo A. Cytokines and hemostasis. Haematologica 85 (2000) 967-972
64. Grundy S.M., Brewer H.B., Cleeman J.I., Smith Jr. S.C., and Lenfant C. American Heart Association, National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
65. Samocha-Bonet D., Lichtenberg D., Tomer A., Deutsch V., Mardi T., Goldin Y., et al. Enhanced erythrocyte adhesiveness/aggregation in obesity corresponds to low-grade inflammation. Obes Res 11 (2003) 403-407
66. Suganami T., Nishiad J., and Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes. Role of free fatty acids and tumor necrosis factor α. Arterioscler Thromb Vasc Biol 25 (2005) 2062-2068
67. Prandoni P., Filora F., Marchiori A., Bernardi E., Petrobelli F., Lensing A.W.A., et al. An association between atherosclerosis and venous thrombosis. New Engl J Med 348 (2003) 1435-1441
68. Becattini C., Agnelli G., Pradoni P., Silingardi P., Salvi R., Taliani M.R., et al. A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J 26 (2005) 77-83
69. Glynn R.J., and Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke and venous thromboembolism. Am J Epidemiol 162 (2005) 975-982
70. Hong C., Shu F., Du D., Pilgram T.K., Sicard G.A., and Bae K.T. Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis 183 (2005) 169-174
71. Bank I., Libourel E.T., Middeldorp S., Hamulyak K., van Panpus E.C., Koopman M.M., et al. Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. J Thromb Haemost 3 (2005) 79-84